Newsroom

Sorted by: Latest

-

Locus Robotics przejmuje Nexera Robotics. W centrum akwizycji przełomowa, opatentowana technologia

WILMINGTON, Mass.--(BUSINESS WIRE)--Locus Robotics, lider w obszarze elastycznej automatyzacji magazynowej, ogłosił przejęcie firmy Nexera Robotics z Vancouver, specjalizującej się w zaawansowanych technologiach chwytania robotycznego. Integracja jej autorskiego rozwiązania, chwytaka NeuraGrasp, z platformą fizycznej AI Locus Robotics znacząco rozszerzy możliwości firmy w zakresie autonomicznej mobilnej manipulacji oraz zwiększy zakres operacji możliwych do zrealizowania w ramach kompleksowych...
-

Locus Robotics übernimmt Nexera Robotics und stärkt seine Lösungen mit patentierter Greiftechnologie

WILMINGTON, Mass.--(BUSINESS WIRE)--Locus Robotics, führend im Bereich flexibel skalierbarer Lagerautomatisierung, gibt heute die Übernahme von Nexera Robotics bekannt. Das in Vancouver ansässige Robotikunternehmen ist auf hochentwickelte robotische Greiftechnologien spezialisiert. Durch die Integration der patentierten NeuraGrasp™-Endeffektor-Technologie von Nexera in die Physical-AI-Plattform von Locus Robotics erweitert das Unternehmen seine Fähigkeiten in der autonomen mobilen Handhabung de...
-

Locus Robotics acquiert Nexera Robotics et fait progresser une innovation brevetée majeure dans la manipulation mobile

WILMINGTON, Mass.--(BUSINESS WIRE)--Locus Robotics, leader de l’automatisation d’entrepôt axée sur la flexibilité, annonce aujourd’hui l’acquisition de Nexera Robotics, une entreprise de robotique basée à Vancouver et spécialisée dans les technologies avancées de manipulation robotique. L’intégration de la technologie propriétaire d’effecteur terminal NeuraGrasp™ de Nexera à la plateforme d’IA physique de Locus Robotics élargit considérablement les capacités de manipulation mobile autonome de l...
-

Locus Robotics Acquires Nexera Robotics, Advancing a Patented Breakthrough in Mobile Manipulation

WILMINGTON, Mass.--(BUSINESS WIRE)--Locus Robotics, the leader in Flexibility-First Warehouse Automation, today announced the acquisition of Nexera Robotics, a Vancouver-based robotics company specializing in advanced robotic grasping. The integration of Nexera’s proprietary NeuraGrasp™ end-effector technology into the Locus Robotics physical AI platform significantly expands the company’s autonomous mobile manipulation capabilities and broadens what Locus Array can handle across end-to-end ful...
-

Locus Robotics adquiere Nexera Robotics y avanza en una innovación patentada en picking autónomo

WILMINGTON, Mass.--(BUSINESS WIRE)--Locus Robotics, líder en automatización de almacenes basada en la flexibilidad, ha anunciado hoy la adquisición de Nexera Robotics, una empresa de robótica con sede en Vancouver especializada en soluciones avanzadas de agarre robótico. La integración de la tecnología patentada de efector final NeuraGrasp™ de Nexera en la plataforma de IA física de Locus Robotics amplía de forma significativa las capacidades de manipulación móvil autónoma de la compañía y expa...
-

Sky Peak Capital Forms Excelus Holdings, One of the Nation’s Leading Independent Precision Manufacturing Platforms

BOSTON--(BUSINESS WIRE)--Sky Peak Capital (“Sky Peak”) today announced the formation of Excelus Holdings (“Excelus”), a scaled precision manufacturing platform created through the combination of Excelus Manufacturing Solutions, D&G Machine Products, and Millennium Precision. With more than 200,000 square feet of combined manufacturing space and over 200 employees, Excelus serves mission-critical aerospace, defense, medical device, power generation, and high-reliability industrial customers....
-

FDA Accepts sNDA and Grants Priority Review to AQNEURSA® for Ataxia-Telangiectasia

AUSTIN, Texas--(BUSINESS WIRE)--IntraBio Inc., a global biopharmaceutical company focused on developing and commercializing therapies for neurological diseases, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review its supplemental New Drug Application (sNDA) for AQNEURSA® (levacetylleucine) for the treatment of Ataxia-Telangiectasia (A-T) in adults and pediatric patients. The FDA simultaneously granted Priority Review and assigned a PDUFA target action date o...
-

Schroders Study Reveals How Retirees Are Responding to the Affordability Crisis

NEW YORK--(BUSINESS WIRE)--More than five years after the onset of the worst US inflation outbreak in a generation, the impact of rising prices continues to trouble retirees. According to Schroders’ 2026 US Retirement Survey, 49% of retirees report that their expenses in retirement are higher than they expected, and more than half (58%) don’t know how long their savings will last. The top five concerns weighing on retired Americans in 2026 include (% at least slightly concerned): Inflation less...
-

Quantum Health Recognizes Clients for Excellence in Healthcare Innovation and Member Experience at Quantum Health Connect 2026

DUBLIN, Ohio--(BUSINESS WIRE)--Quantum Health, the leading healthcare navigation company, today announced the winners of its annual client awards at Quantum Health Connect 2026, recently held in Nashville. The awards recognize organizations transforming the healthcare experience and delivering measurable impact across cost, experience and clinical outcomes, while highlighting achievements in innovation, whole-person care, employee engagement and overall health performance. This year’s Quantum H...
-

Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands)

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, branded specialty pharmaceutical company, announced today it has appointed David Bell as Chief Commercial Officer (Brands). David joins the company’s executive leadership team as it continues to advance its ambitions in specialty pharmaceuticals and expand its commercial platform and portfolio. In this new role, David will oversee all branded commercial functions – including sales, marketing, market access, commerc...